SWP
IONS icon

Stratos Wealth Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Stratos Wealth Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$619K Buy
7,801
+86
+1% +$6.47K 0.01% 1048
2026
Q1 		$579K Sell
7,715
-25
-0.3% -$1.97K 0.01% 1012
2025
Q4 		$612K Sell
7,740
-24
-0.3% -$1.81K 0.01% 959
2025
Q3 		$508K Buy
+7,764
New +$379K 0.01% 1010
2025
Q1 		– Sell
-12,813
Closed -$448K – 1440
2024
Q4 		$448K Buy
12,813
+25
+0.2% +$934 0.01% 982
2024
Q3 		$512K Sell
12,788
-3
-0% -$140 0.01% 936
2024
Q2 		$610K Buy
+12,791
New +$525K 0.01% 829
2020
Q3 		– Sell
-4,296
Closed -$253K – 1034
2020
Q2 		$253K Sell
4,296
-456
-10% -$25.4K 0.01% 822
2020
Q1 		$225K Buy
+4,752
New +$265K 0.01% 773
2018
Q4 		– Sell
-862
Closed -$44K – 1631
2018
Q3 		$44K Buy
+862
New +$40.5K ﹤0.01% 1513
2018
Q2 		– Sell
-1,611
Closed -$71K – 1754
2018
Q1 		$71K Sell
1,611
-482
-23% -$24.5K ﹤0.01% 1384
2017
Q4 		$105K Buy
+2,093
New +$115K ﹤0.01% 1167

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Stratos Wealth Partners's IONS Position: Q2 2026 in Review

Stratos Wealth Partners increased its Ionis Pharmaceuticals (IONS) stake by 1.1% in Q2 2026, buying an estimated $6.47K and bringing the position to 7,801 shares worth $619K. The position accounts for 0.01% of the portfolio, ranked #1048.

Stratos Wealth Partners first reported a position in IONS in Q4 2017 and has held it in 12 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Stratos Wealth Partners held 7,801 shares of Ionis Pharmaceuticals worth $619K as of Q2 2026.
  • Stratos Wealth Partners bought 86 Ionis Pharmaceuticals shares in Q2 2026, an estimated $6.47K.
  • Ionis Pharmaceuticals made up 0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #1048 holding.
  • Stratos Wealth Partners first reported a position in Ionis Pharmaceuticals in Q4 2017 and has held it in 12 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.